Vitamin D3 for Life

Live Enlightened

Physiology

Paracrine Vitamin D Signalling: Full Study

Previous related pageLiver Disease, Carrier Proteins and Vitamin D Availability: Study SummaryNext related pagePlasma Transport of Vitamin D Metabolites: Evidence Synthesis
Study at a glance

Can one cell make active vitamin D that affects a nearby cell?

Can one cell make active vitamin D and change how a nearby cell responds? Six studies tested this question and its connections with the supply of starting vitamin D compound in blood and kidney control. They used human cells grown in the laboratory and specially altered mice.

What affected communication between vitamin D-producing cells and nearby cells?

Some cell experiments supported communication from a producing cell to another cell. Responding cells could also make active vitamin D themselves. Timing, the way cells were stimulated, and proteins that bind vitamin D compounds changed the results. Mouse studies found active vitamin D outside the kidney. In one kidney-altered model, blood hormone levels stayed similar to controls even though a hormone that helps control blood calcium rose, and bone density fell.

Can a blood test show how tissues make and use active vitamin D?

A local response depends on the cells involved and their access to the starting vitamin D compound. A blood level does not show how much active vitamin D each tissue makes, breaks down or uses.

Do these cell and mouse studies establish benefits or doses for people?

Cells in a dish and altered mice do not establish a health benefit or supplement dose for people. The studies did not trace every hormone molecule or measure how much hormone moves through each human tissue over time. Some papers involved connected research teams.

Read the full article below ↓

Vitamin D can participate in local communication when a producing cell changes the response of a nearby cell. The evidence is more specific than the general statement that vitamin D acts throughout the body. This review compares human-cell experiments that test local production and recipient responses with mouse studies of nonrenal production and whole-body feedback. It asks both what supports a paracrine route and how that route depends on circulating supply. Paracrine Vitamin D Signalling: Study Summary

StudyWhat was observed?What does the result leave uncertain?
Jeffery 2012Fluid from human dendritic cells changed CTLA-4, a protein involved in controlling responses, on separately stimulated T cells. Both are immune-cell types.This laboratory result did not measure a health benefit or the amount of active hormone normally made in human tissues.
Kongsbak 2014Stimulated human T cells developed the ability to change the starting vitamin D compound into active hormone. Binding protein and serum, the liquid part of blood, limited some responses.Responding cells can make their own active hormone. Timing and the surrounding liquid matter when deciding where a signal came from.
Villalba Lopez 2021Macrophages, another immune-cell type, made different amounts of active hormone under different laboratory conditions. They changed responses in T cells grown with them.The highest tested carrier-protein concentration was below the usual blood concentration. Laboratory cell categories do not represent all cells in tissues.
Chauss 2022Changing parts of a vitamin D pathway in human T cells changed a particular pattern of cell responses.Cells making their own hormone provide another possible explanation for a local response. This was not another transfer experiment between different cell types.
Meyer 2024Chemical imaging detected active vitamin D outside the kidney in specially altered mice.The small samples and unusual diets limit the conclusion. The amount found does not show how much was made or moved per unit of time.
Lee 2025Blood active-hormone levels stayed similar to controls in two kidney-altered mouse models. In the more affected model, a hormone that helps control blood calcium rose and bone density fell.Some kidney production and slower hormone breakdown could help maintain blood levels. The study did not measure the share supplied by each organ.
These experiments answer different questions. Some papers involved connected research teams; the six papers are not six separate teams confirming one health benefit.

What would demonstrate a local signalling route?

Paracrine signalling means that a substance produced by one cell acts on another nearby cell. Autocrine signalling refers to a substance returning to the producing cell, while intracrine activity describes production and use within a target cell. These terms identify different routes. Finding a vitamin D-related response in a group of cells does not, by itself, identify which route carried the signal. The distinction is introduced in Vitamin D and Intracrine Activity.

The vitamin D compounds also need separate names. Vitamin D3, or cholecalciferol, is not the same substance as 25-hydroxyvitamin D, the circulating precursor commonly measured in blood. The enzyme CYP27B1 can convert that precursor into calcitriol, also called 1,25-dihydroxyvitamin D. Calcitriol activates the vitamin D receptor. Adding active calcitriol directly to a culture therefore asks a different question from supplying precursor and testing whether the cells activate it.

A persuasive local-production experiment needs more than an enzyme measurement. It may measure the product, interfere with conversion, separate producing and responding populations, or transfer culture fluid to a new recipient population. These approaches test different parts of the proposed sequence. Even their combination does not necessarily trace every molecule from its source to a particular receptor inside a recipient cell.

This distinction also prevents confusion between vitamin D metabolites and other local signals. Vitamin D exposure can change the cytokines, proteins used for cell communication, released by a cell. Those cytokines may then influence another cell. That is local communication associated with vitamin D, but it is not automatically evidence that the transferred active substance was calcitriol. The studies below help distinguish production, availability and response without assuming that every neighbour effect uses the same route. A comparison of cell-specific inflammatory responses is developed in Vitamin D and Inflammatory Signalling Across Cell Types: Full Evidence Review.

A producer-to-recipient experiment in human immune cells

Jeffery and colleagues in 2012 studied human dendritic cells and T cells in laboratory cultures. Dendritic cells can present antigens and interact with T cells. The researchers compared precursor with active hormone, measured conversion-related activity, used an inhibitor, and examined what happened when fluid from one culture was supplied to another. This design addresses local metabolite availability more directly than receptor expression alone.

In an early comparison, dendritic cells produced detectable calcitriol after precursor exposure. Purified T cells did not show the same detectable production during that particular 24-hour experiment. Fluid from precursor-exposed dendritic-cell cultures changed CTLA-4 expression in separately stimulated T cells. CTLA-4 is a receptor involved in controlling T-cell responses. This recipient experiment supports a functional producer-to-recipient route under the tested conditions.

The product assay nevertheless required care. The investigators found substantial loss of vitamin D material during measurement without a carrier protectant and applied a recovery correction. Corrected concentrations should not be presented as if they were uncorrected quantities directly recovered from a tissue. The product and substrate-use panels included representative experiments, rather than one large clinical sample from which a precise normal human production rate could be calculated.

Contact between activated T cells and dendritic cells helped induce CYP27B1. The producing population was therefore responding to its cellular environment; it was not simply releasing a fixed amount of hormone regardless of its neighbours. However, the measured T-cell markers and cytokines are not equivalent to demonstrated protection from infection or inflammatory disease. A regulatory marker also does not establish that every responding cell became a stable regulatory T cell. Related functional experiments using directly supplied calcitriol are examined in Vitamin D, CTLA-4 and Immune Restraint: Full Study.

Taken together, the measured product, conversion-related perturbation and recipient response support local vitamin D activity. They do not prove that calcitriol was the only active component of every transferred sample, or that the same concentrations occur in living human tissues. The conclusion is conditional experimental support, with a visible causal limit.

Carrier binding and activation time change the interpretation

Vitamin D-binding protein is a major carrier of vitamin D metabolites in blood. A culture containing precursor without comparable protein binding can make the precursor much easier for cells to use than a protein-rich environment. Nominal precursor concentration alone therefore does not define the exposure experienced by the cell. This transport question is developed in Vitamin D Binding Protein Explained.

In Jeffery’s experiments, adding binding protein reduced precursor-driven conversion and T-cell responses. Kongsbak and colleagues in 2014 examined another side of the problem: activated human T cells could themselves develop conversion capacity over a longer activation period. In their serum-free system, production and several responses became apparent around the second to third day. Carrier protein or serum strongly restricted precursor-driven activity, while responses to directly supplied active hormone were less affected.

The early dendritic-cell comparison and the later activated-T-cell result should not be flattened into opposing universal claims. They used different activation times and culture conditions. Their comparison shows why timing and medium matter; it does not isolate one condition as the complete explanation of every difference. Neither paper justifies saying that T cells always make their own active vitamin D or never do so.

Kongsbak’s work also separated uptake of carrier protein from useful delivery of its vitamin D cargo. Detecting internalised protein or a transcript for an uptake receptor did not establish that a particular uptake route supplied enough usable precursor. This matters because a cell can contain transport-related machinery without producing the expected downstream response. The cellular-entry question is developed in Cellular uptake and intracellular handling of vitamin D metabolites: Full Evidence Review. The experiments do not establish that a free-vitamin-D blood test is universally superior to the usual total measurement. The separate measurement problem is examined in DBP Variability and Free vs Total Vitamin D: Evidence Synthesis.

The practical inference concerns experimental attribution. A recipient response might depend on hormone supplied by another cell, hormone produced within the recipient population, or both. To identify a paracrine contribution, the investigator must consider the recipient’s activation state, its own conversion capacity and the precursor remaining in the medium. The label “local signalling” is broader than proof of a unique producer-to-recipient path.

Macrophage state changes local availability

Villalba Lopez and colleagues in 2021 compared human macrophages prepared under different laboratory activation conditions, isolated T cells and macrophage: T-cell co-cultures. Their operational macrophage states produced different amounts and time courses of calcitriol after precursor exposure. One inflammatory activation condition generated more measured product and supported responses in the neighbouring T-cell system more strongly than the alternative condition.

The binding-protein comparison was especially informative. Some macrophage conditions and co-cultures retained appreciable production when binding protein greatly restricted isolated T-cell activity. This supports the idea that an activated producer population can change the local environment available to another cell.

The result was not complete resistance to binding protein. Some responses weakened as carrier concentration increased. The highest experimental concentration, 1 micromole per litre, was below the approximately 5 micromoles per litre cited for normal serum. The study therefore did not show that the cultures overcame normal full-serum binding conditions. Laboratory macrophage categories also simplify the range of states found in real tissues.

Different cytokines and transcription-factor measurements did not all move together. Some cytokines were undetectable in the tested co-cultures. Small, panel-specific donor groups and substantial variation limit precision, and the reported panel counts cannot safely be summed into a unique overall patient population. The macrophage and earlier T-cell papers came from an overlapping research programme; distinct experiments are not the same thing as independent replication by unrelated laboratories.

This study adds functional context to the transfer question. It shows that the state of a producing cell population can affect precursor handling and recipient responses. It does not show that every macrophage is a reliable calcitriol supplier, that every recipient effect is caused exclusively by transferred hormone, or that oral supplementation reproduces the culture result.

A cell’s own pathway can resemble a neighbour effect

Chauss and colleagues in 2022 examined an activation-dependent vitamin D pathway in human T cells. They combined precursor and active-hormone experiments with perturbation of CYP27B1, the vitamin D receptor and other components of a defined cellular response circuit. Their findings connect local activation with changes in the inflammatory programme and an interleukin-10 response involving interleukin-6 and STAT3, a protein involved in gene regulation.

This is a useful alternative route, not another independent demonstration that dendritic cells exported active hormone to T cells. A purified cell population can produce a hormone and respond to it while still allowing some hormone to leave a cell and return locally. The experiments do not establish exclusive intracellular retention. Their own autocrine framing is therefore more precise than treating all cell-intrinsic production as proven strictly intracrine action.

The cytokine circuit was also context-specific. Interleukin-6 contributed to the measured response under those activation conditions; that does not make interleukin-6 universally anti-inflammatory. Nor did the experiments demonstrate a general conversion of T cells into one beneficial phenotype. The work supports an organised change in a particular cellular programme, with molecular perturbations strengthening the inference beyond a simple association.

For the paracrine question, its contribution is interpretive. If responding cells can generate active hormone and organise their own local feedback, an observed response near another cell cannot automatically be assigned to hormone from that neighbour. This does not erase the positive transfer evidence. It specifies what additional controls are needed before identifying the route.

How does circulating supply connect with local action?

The cell studies establish several links between systemic supply and local responses. Circulating precursor can supply the starting material. Carrier binding can restrict access. Activation state can change conversion, and the recipient’s own machinery can change its response. These are experimentally tested connections, but they are not measurements of the fraction of a person’s circulating hormone produced by every tissue.

The distinction between precursor and active-hormone measurements is explained in 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Physiological Meaning and Regulation: Full Study. A blood concentration is an observable pool at a sampling time. It does not directly reveal production rate, breakdown rate or active-hormone concentration inside each local environment. Increasing one measured pool is therefore not proof that every tissue response increased in the same way.

Meyer and colleagues in 2024 addressed the organ-scale question with specialised mice in which renal Cyp27b1 regulatory elements were disrupted while nonrenal regulation was retained. They used targeted mass spectrometry imaging, supported by measurements in tissue homogenates, to examine nonrenal calcitriol. The study found evidence particularly in the spleen, adding direct localisation information beyond a list of enzyme-positive cells.

These mice required an unusual experimental context, including mineral rescue and contrasting vitamin D diets. Imaging involved small biological samples, and spatial resolution and possible movement during processing limit a claim about precisely which individual cell produced each signal. A diet without added vitamin D did not establish serum deficiency during the examined interval. The dietary contrast cannot be converted into an ordinary human intake recommendation.

Selected splenic cytokine transcripts changed, while others did not show clear changes. Local metabolite measurements and selected tissue-response transcripts were examined in the same experiment. The study does not establish that calcitriol alone caused every cytokine change, a uniform immune benefit, or secretion into the blood at a rate inferred from tissue concentration. Tissue-Specific Vitamin D Metabolism provides the broader tissue-metabolism setting, while Where Vitamin D Acts distinguishes the locations of vitamin D action.

Normal circulating hormone does not guarantee normal physiology

Lee and colleagues in 2025 provide an important qualification from different kidney-targeted Cyp27b1 deletion models. Despite strong changes in enzyme-related measurements and altered precursor and catabolite profiles, circulating calcitriol was not clearly reduced compared with wild-type mice. In the more affected model, parathyroid hormone was higher and bone mineral density lower; male calcium was also reduced.

Preserved circulating active hormone therefore did not mean that the physiological system was normal. At the same time, the experiment did not uniquely prove that nonrenal production supplied all the retained hormone. Reduced catabolism, residual renal enzyme activity and other compensation remained possible. The investigators could not reliably quantify normal versus residual CYP27B1 protein, and some targeting was not perfectly confined to the kidney.

The Meyer and Lee papers also share a research programme, model-development history and analytical collaborators. They provide complementary experiments, not replication by independent laboratories. No hormone half-life or complete production-versus-clearance flux was measured. The separate evidence on hormone persistence and breakdown is examined in Cellular degradation and feedback regulation of vitamin D: Full Evidence Review. The qualitative pattern is useful for understanding compensation; it is not a precise calculation of organ contributions. The central point is the observed separation between a blood hormone concentration and wider mineral and skeletal physiology.

Local activation and breakdown therefore need to be considered together. From Vitamin D Activation to Clearance: The CYP27B1: CYP24A1 Balance explains that connected metabolism, while Intracrine conversion and local control of vitamin D metabolism: Full Evidence Review develops the conversion and local-control stage in detail. These connections do not imply that local tissues are independent of the body’s supply and feedback systems.

What can this evidence establish?

The strongest evidence for a producer-to-recipient route comes from experiments that separate the populations or transfer their culture fluid, measure product and perturb conversion. Evidence from carrier manipulation and activated recipient cells makes the interpretation more realistic: a nearby response depends on exposure conditions and the receiving cell, not just the presence of a potential producer.

Mouse localisation and renal-perturbation studies add a second scale. They show that nonrenal production and compensation deserve investigation, and that circulating hormone cannot be treated as a complete description of tissue activity. They do not supply a quantitative map of local human hormone flow. More samples, more measured genes or several assays within one paper do not turn one experimental programme into multiple independent confirmations.

The six studies answer complementary parts of the question. They support conditional local vitamin D signalling and its dependence on precursor supply, carrier binding, cellular state and organ feedback. They do not establish universal paracrine activity in every tissue, a general clinical benefit from increasing vitamin D, or a treatment dose. Those conclusions would require evidence with the appropriate people, interventions and outcomes.

Scientific sources

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. Jeffery LE, Wood AM, Qureshi OS, et al. Journal of immunology (Baltimore, Md. : 1950). 2012;189(11):5155-64. DOI: 10.4049/jimmunol.1200786.

Vitamin D-binding protein controls T cell responses to vitamin D. Kongsbak M, von Essen MR, Levring TB, et al. BMC immunology. 2014;15:35. DOI: 10.1186/s12865-014-0035-2.

Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses. Lopez DV, Al-Jaberi FAH, Woetmann A, et al. Frontiers in immunology. 2021;12:722806. DOI: 10.3389/fimmu.2021.722806.

Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Chauss D, Freiwald T, McGregor R, et al. Nature immunology. 2022;23(1):62-74. DOI: 10.1038/s41590-021-01080-3.

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging. Meyer MB, Lee SM, Cichanski SR, et al. JCI insight. 2024;9(15). DOI: 10.1172/jci.insight.181763.

Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3. Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106734. DOI: 10.1016/j.jsbmb.2025.106734.

Related reading

Original sources

Source

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses

Published in Jeffery LE, Wood AM, Qureshi OS, et al. Journal of immunology (Baltimore, Md. : 1950) (2012).

Publication details

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. Jeffery LE, Wood AM, Qureshi OS, et al. Journal of immunology (Baltimore, Md. : 1950). 2012;189(11):5155-64. DOI: 10.4049/jimmunol.1200786.

Read more →
Source

Vitamin D-binding protein controls T cell responses to vitamin D

In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation.

Publication details

Vitamin D-binding protein controls T cell responses to vitamin D. Kongsbak M, von Essen MR, Levring TB, et al. BMC immunology. 2014;15:35. DOI: 10.1186/s12865-014-0035-2.

Read more →
Source

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging

Here, utilizing on-tissue chemical derivatization and matrix assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI), we investigated the distribution of 1,25(OH)2D3 and 25(OH)D3 in the kidney, liver, spleen, and thymus.

Publication details

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging. Meyer MB, Lee SM, Cichanski SR, et al. JCI insight. 2024;9(15). DOI: 10.1172/jci.insight.181763.

Read more →
Source

Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3

Published in Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology (2025).

Publication details

Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3. Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106734. DOI: 10.1016/j.jsbmb.2025.106734.

Read more →